DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 124 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $175 | -14.6% | 12,429 | -6.5% | 0.01% | -6.7% |
| Q1 2023 | $205 | -5.5% | 13,288 | +0.4% | 0.02% | -16.7% |
| Q4 2022 | $217 | -99.9% | 13,239 | -4.7% | 0.02% | -25.0% |
| Q3 2022 | $257,000 | +8.9% | 13,887 | -22.6% | 0.02% | +14.3% |
| Q2 2022 | $236,000 | +20.4% | 17,953 | -15.3% | 0.02% | +250.0% |
| Q1 2022 | $196,000 | +12.0% | 21,190 | +18.2% | 0.01% | 0.0% |
| Q4 2021 | $175,000 | – | 17,933 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $11,213,000 | 5.53% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,580,456 | $51,731,000 | 1.16% |
| ARMISTICE CAPITAL, LLC | 5,836,000 | $54,100,000 | 1.05% |
| Pinz Capital Management, LP | 165,835 | $1,537,000 | 0.96% |
| Sunesis Advisors, LLC | 96,299 | $893,000 | 0.52% |
| Redmile Group, LLC | 664,817 | $6,163,000 | 0.19% |
| PDT Partners, LLC | 222,343 | $2,061,000 | 0.18% |
| Bayesian Capital Management, LP | 41,900 | $388,000 | 0.06% |
| Laurion Capital Management LP | 459,290 | $4,258,000 | 0.05% |
| Hennion & Walsh Asset Management, Inc. | 101,643 | $942,000 | 0.05% |